United Therapeutics (UTHR) EBIT Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) EBIT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | -341.00 |
| 10 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | -538.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -341.00 |
| Mar 31, 2026 | -650.00 |
| Dec 31, 2025 | -347.00 |
| Sep 30, 2025 | 278.00 |
| Jun 30, 2025 | 89.00 |
| Mar 31, 2025 | -439.00 |
| Dec 31, 2024 | 629.00 |
| Sep 30, 2024 | -785.00 |
| Jun 30, 2024 | -779.00 |
| Mar 31, 2024 | -353.00 |
| Dec 31, 2023 | 659.00 |
| Sep 30, 2023 | -725.00 |
| Jun 30, 2023 | 932.00 |
| Mar 31, 2023 | -625.00 |
| Dec 31, 2022 | -517.00 |
| Sep 30, 2022 | 948.00 |
| Jun 30, 2022 | -654.00 |
| Mar 31, 2022 | 7,944.00 |
| Dec 31, 2021 | 2,393.00 |
| Sep 30, 2021 | -674.00 |